Skip to main content


Figure 2 | Clinical and Translational Allergy

Figure 2

From: Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial

Figure 2

Summary of the FEV 1 time course of mean absolute FEV 1 from Day 1 pre-dose to 2 h post allergen challenge (A) and mean FEV 1 change from allergen challenge post-saline baseline measure (B). Therapy was dosed between 6 pm and 8 pm on Days 1–28 and the allergen challenge initiated on Day 29 (between 4 pm and 7 pm). FEV1 = forced expiratory volume in 1 s; FF = fluticasone furoate; L = litres; SE = standard error; VI = vilanterol. Not all subjects contributed data to all time points

Back to article page